G W Canonica Selected Research

Rhinitis

1/2016	ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
3/2014	Clinical relevance is associated with allergen-specific wheal size in skin prick testing.
1/2014	Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.
8/2013	The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy.
1/2013	Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
4/2012	Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study.
12/2011	Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosis.
9/2011	Specific immunotherapy in asthma: efficacy and safety.
6/2011	Allergic rhinitis in asthma.
7/2010	The clinical efficacy of a sublingual monomeric allergoid at different maintenance doses: a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G W Canonica Research Topics

Disease

51	Asthma (Bronchial Asthma) 01/2022 - 01/2000
35	Hypersensitivity (Allergy) 01/2018 - 01/2000
25	Rhinitis 01/2016 - 06/2000
23	Allergic Rhinitis 01/2022 - 09/2000
19	Inflammation (Inflammations) 06/2021 - 06/2000
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 05/2001
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017 - 04/2012
4	Airway Remodeling 04/2012 - 10/2002
4	Perennial Allergic Rhinitis 12/2009 - 09/2001
3	Nasal Polyps (Nasal Polyp) 06/2021 - 05/2003
3	Respiratory Tract Infections (Respiratory Tract Infection) 07/2011 - 11/2004
3	Infections 05/2007 - 11/2004
2	Urticaria (Hives) 05/2019 - 10/2001
2	Rhinosinusitis 09/2017 - 03/2002
2	Respiratory Hypersensitivity 01/2017 - 08/2008
2	Food Hypersensitivity (Food Allergy) 03/2014 - 12/2012
2	Conjunctivitis 12/2012 - 10/2001
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2011 - 09/2001
2	Pruritus (Itching) 01/2003 - 04/2001
1	Chronic Urticaria 05/2019
1	Symptom Flare Up 01/2017
1	Frailty 01/2017
1	Anaphylaxis (Anaphylactic Shock) 07/2015
1	Bites and Stings (Sting) 01/2015
1	Cold Urticaria 01/2015
1	Mastocytosis 01/2015
1	Venom Hypersensitivity 07/2014
1	Atopic Dermatitis (Atopic Eczema) 03/2014
1	Coronary Disease (Coronary Heart Disease) 08/2012
1	Disease Progression 06/2012
1	Eosinophilia 12/2009
1	Vascular Diseases (Vascular Disease) 11/2008
1	Chronic Disease (Chronic Diseases) 08/2008
1	Virus Diseases (Viral Diseases) 05/2007

Drug/Important Bio-Agent (IBA)

32	AllergensIBA 07/2014 - 01/2000
15	Immunoglobulin E (IgE)IBA 01/2017 - 09/2000
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 04/2001
8	Pharmaceutical PreparationsIBA 02/2021 - 01/2001
7	Histamine Antagonists (Antihistamines)IBA 01/2018 - 01/2001
6	Methacholine Chloride (Methacholine)FDA Link 01/2017 - 04/2000
5	CytokinesIBA 08/2004 - 01/2002
4	Mometasone Furoate (Nasonex)FDA LinkGeneric 05/2011 - 04/2001
4	Nasal SpraysIBA 05/2011 - 01/2001
3	Monoclonal AntibodiesIBA 06/2021 - 06/2007
3	Biological ProductsIBA 02/2021 - 01/2001
3	Omalizumab (Xolair)FDA Link 05/2019 - 03/2005
3	Formoterol Fumarate (Oxis)FDA Link 10/2012 - 01/2004
3	anti-IgE antibodiesIBA 04/2012 - 09/2006
3	desloratadine (Aerius)FDA LinkGeneric 10/2009 - 03/2005
3	Albuterol (Salbutamol)FDA LinkGeneric 04/2008 - 04/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007 - 04/2001
2	SteroidsIBA 09/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2012
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2015 - 09/2000
2	TabletsIBA 10/2014 - 01/2001
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 04/2005
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2012 - 01/2004
2	LeukotrienesIBA 04/2012 - 12/2009
2	fexofenadine (Allegra)FDA LinkGeneric 01/2011 - 11/2001
2	AllergoidsIBA 07/2010 - 07/2006
2	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 08/2008 - 04/2008
2	Cetirizine (Zyrtec)FDA LinkGeneric 09/2001 - 04/2000
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2001 - 04/2001
1	Interleukin-4 (Interleukin 4)IBA 06/2021
1	dupilumabIBA 06/2021
1	Interleukin-13IBA 06/2021
1	Generic DrugsIBA 02/2021
1	mepolizumabIBA 01/2019
1	benralizumabIBA 12/2017
1	SmokeIBA 09/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	aclidinium bromideIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	rupatadineIBA 01/2015
1	Platelet Activating FactorIBA 01/2015
1	MP29-02IBA 01/2014
1	Natural Killer Cell ReceptorsIBA 10/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2012
1	GlucocorticoidsIBA 04/2012
1	montelukast (Singulair)FDA Link 04/2012
1	Leukotriene Receptors (Leukotriene Receptor)IBA 04/2012
1	AntibodiesIBA 04/2012
1	Profilins (Profilin)IBA 12/2011
1	Broncho-VaxomIBA 07/2011
1	CholesterolIBA 11/2008
1	Atorvastatin (Lipitor)FDA Link 11/2008
1	Simvastatin (Zocor)FDA LinkGeneric 11/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2008
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2008
1	Fluvastatin FDA Link 11/2008
1	Interleukin-12 (IL 12)IBA 06/2007

Therapy/Procedure

21	Therapeutics 01/2022 - 01/2000
16	Immunotherapy 01/2016 - 01/2001
6	Drug Therapy (Chemotherapy) 09/2011 - 01/2001
2	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2017
2	Nebulizers and Vaporizers (Inhaler) 01/2020 - 01/2004
2	Precision Medicine 09/2017 - 01/2016
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2020
1	Dry Powder Inhalers 01/2020
1	Polypharmacy 01/2017